文献速递自身炎症与 IgG4 相关病血管炎

自身炎症综合征患者灰阶、彩色多普勒及示波法大血管病变指标:INFLAMMACARD队列

Greyscale, colour Doppler and oscillometric macroangiopathy indices in patients with autoinflammatory syndromes: the INFLAMMACARD cohort.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究首次在自身炎症综合征(AIS)患者中联合应用彩色多普勒超声、灰阶超声和示波法评估血管病变指标,并与健康对照比较。结果显示AIS患者颈动脉搏动指数和收缩期峰值流速升高,未接受生物制剂治疗者主动脉僵硬度更高;主动脉僵硬度与颈动脉内中膜厚度主要由年龄、收缩压和淋巴结病预测。

要点

  • AIS患者颈动脉搏动指数和收缩期峰值流速显著高于健康对照。
  • 未接受生物制剂治疗的AIS患者主动脉僵硬度(cfPWV)显著升高。
  • 年龄、收缩压和淋巴结病是cfPWV与cIMT的主要预测因素。

核心结论

  • AIS患者表现出颈动脉搏动性增加和血流动力学改变,未接受生物制剂者主动脉僵硬度更高。
  • 血管病变标志物可能揭示AIS患者显著的血管异常,有助于改善心血管筛查和风险分层。

主要发现

  • AIS患者颈总动脉搏动指数为1.89(0.46) vs 1.59(0.32),P=0.024;收缩期峰值流速为80.15 vs 64.95 cm/s,P=0.003。
  • 未接受生物制剂治疗的AIS患者cfPWV为6.99(1.71) vs 5.86(0.81) m/s,P=0.001。
  • cfPWV与年龄相关(rho=0.573,P<0.001),与收缩压相关(r=0.464,P=0.009),与淋巴结病相关(eta=0.373,P=0.039)。
  • cIMT与年龄相关(rho=0.675,P=0.002),与收缩压相关(rho=0.514,P=0.029)。
  • 搏动指数与尼古丁相关(rho=0.691,P=0.008),流速积分与收缩压呈负相关(rho=-0.522,P=0.026)。

临床怎么用

  • 在AIS患者心血管风险评估中可考虑联合应用示波法和动脉超声检测血管病变标志物。
  • 对未接受生物制剂治疗的AIS患者应关注主动脉僵硬度增加的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate for the first time a combination of novel colour Doppler ultrasound (CDUS), greyscale (GSUS) and oscillometric indices of angiopathy in patients with autoinflammatory syndromes (AIS). Further, to explore the associations between these markers and patient- and disease-related characteristics, as well as traditional cardiovascular (CV) risk factors. METHODS: CDUS was used to assess arterial compliance markers, such as resistance index, pulsatility index (PI) and flow-velocity integral (FVI) in the common carotid artery (CCA) of AIS patients and healthy controls. Additionally, GSUS was employed to measure carotid intima-media thickness (cIMT), detect plaques and quantify total calcification surface. Oscillometry was utilized to evaluate aortic stiffness by carotid-femoral pulse wave velocity (cfPWV). RESULTS: Thirty-one patients with AIS and 62-matched (1:2) healthy controls were recruited. AIS patients exhibited higher CCA-PI [1.89 (0.46) vs 1.59 (0.32), P = 0.024] and peak systolic velocity (80.15 vs 64.95 cm/s, P = 0.003), compared with controls. Moreover, AIS patients not receiving biologic therapy demonstrated significantly higher cfPWV [6.99 (1.71) vs 5.86 (0.81) m/s, P = 0.001]. cfPWV and cIMT were predicted by age (cfPWV: rho = 0.573, P < 0.001; cIMT: rho = 0.675, P = 0.002), systolic arterial pressure (SAP) (cfPWV: r = 0.464, P = 0.009; cIMT: rho = 0.514, P = 0.029) and lymphadenopathy (cfPWV: eta = 0.373, P = 0.039). PI associated with nicotine (rho = 0.691, P = 0.008) and FVI (inversely) with SAP (rho = -0.522, v0.026). CONCLUSION: In the first CV surrogate marker study in AIS combining oscillometry and arterial US, patients exhibited increased carotid pulsatility and altered flow dynamics vs controls. Aortic stiffness was lower in patients receiving biologics and mainly predicted by traditional CV factors and lymphadenopathy. Angiopathy markers may reveal significant vascular abnormalities in AIS patients, improving CV screening and risk classification.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Triantafyllias K, Mandel A, Dimitroulas T, et al. Greyscale, colour Doppler and oscillometric macroangiopathy indices in patients with autoinflammatory syndromes: the INFLAMMACARD cohort. Rheumatology (Oxford). 2026. PMID: 41520168. doi:10.1093/rheumatology/keag017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。